avrg: SARS-CoV-2 Analysis Results (GEO series: GSE147507)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
ZNF143
|
ENSG00000166478.5 | zinc finger protein 143 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
ZNF143 | hg19_v2_chr11_+_9482551_9482604 | 0.57 | 8.0e-03 | Click! |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.8 | 17.5 | GO:0070631 | spindle pole body duplication(GO:0030474) spindle pole body organization(GO:0051300) spindle pole body localization(GO:0070631) establishment of spindle pole body localization(GO:0070632) spindle pole body localization to nuclear envelope(GO:0071789) establishment of spindle pole body localization to nuclear envelope(GO:0071790) |
2.9 | 8.7 | GO:0070510 | regulation of histone H4-K20 methylation(GO:0070510) positive regulation of histone H4-K20 methylation(GO:0070512) |
2.0 | 6.0 | GO:0098939 | dendritic transport of mitochondrion(GO:0098939) anterograde dendritic transport of mitochondrion(GO:0098972) |
2.0 | 6.0 | GO:1901340 | negative regulation of store-operated calcium channel activity(GO:1901340) |
1.6 | 9.5 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
1.5 | 6.1 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
1.3 | 4.0 | GO:1903461 | Okazaki fragment processing involved in mitotic DNA replication(GO:1903461) |
1.3 | 7.8 | GO:0030423 | targeting of mRNA for destruction involved in RNA interference(GO:0030423) |
1.3 | 3.8 | GO:0036466 | synaptic vesicle recycling via endosome(GO:0036466) |
1.3 | 10.1 | GO:1903751 | regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903750) negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903751) |
1.2 | 8.4 | GO:0035624 | receptor transactivation(GO:0035624) |
1.2 | 4.6 | GO:0006601 | creatine biosynthetic process(GO:0006601) |
1.1 | 26.5 | GO:1990001 | inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
1.1 | 3.2 | GO:0035621 | ER to Golgi ceramide transport(GO:0035621) |
1.0 | 3.0 | GO:0016260 | selenocysteine biosynthetic process(GO:0016260) |
1.0 | 3.9 | GO:0016598 | protein arginylation(GO:0016598) |
0.9 | 3.6 | GO:0051754 | meiotic sister chromatid cohesion, centromeric(GO:0051754) |
0.9 | 2.6 | GO:1903595 | positive regulation of histamine secretion by mast cell(GO:1903595) |
0.9 | 2.6 | GO:0032203 | telomere formation via telomerase(GO:0032203) |
0.8 | 3.4 | GO:1904116 | response to vasopressin(GO:1904116) cellular response to vasopressin(GO:1904117) |
0.8 | 2.4 | GO:1990426 | homologous recombination-dependent replication fork processing(GO:1990426) |
0.8 | 4.7 | GO:0035407 | histone H3-T11 phosphorylation(GO:0035407) |
0.8 | 9.1 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
0.7 | 2.9 | GO:0033567 | DNA replication, Okazaki fragment processing(GO:0033567) |
0.7 | 2.2 | GO:1905051 | regulation of base-excision repair(GO:1905051) positive regulation of base-excision repair(GO:1905053) |
0.7 | 2.8 | GO:0032053 | ciliary basal body organization(GO:0032053) |
0.7 | 2.0 | GO:0000349 | generation of catalytic spliceosome for first transesterification step(GO:0000349) |
0.6 | 3.2 | GO:0071460 | cellular response to cell-matrix adhesion(GO:0071460) |
0.6 | 3.8 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.6 | 3.1 | GO:1990180 | mitochondrial tRNA 3'-end processing(GO:1990180) |
0.6 | 3.6 | GO:0060355 | positive regulation of cell adhesion molecule production(GO:0060355) |
0.6 | 3.0 | GO:1904565 | response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
0.6 | 3.5 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
0.6 | 2.8 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
0.5 | 3.2 | GO:2001153 | regulation of renal water transport(GO:2001151) positive regulation of renal water transport(GO:2001153) |
0.5 | 1.6 | GO:0006272 | leading strand elongation(GO:0006272) |
0.5 | 2.7 | GO:0044208 | 'de novo' AMP biosynthetic process(GO:0044208) |
0.5 | 3.2 | GO:1903588 | negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903588) |
0.5 | 3.1 | GO:0016321 | female meiosis chromosome segregation(GO:0016321) |
0.5 | 2.0 | GO:0051097 | negative regulation of helicase activity(GO:0051097) oligodendrocyte apoptotic process(GO:0097252) |
0.5 | 2.5 | GO:1901979 | regulation of inward rectifier potassium channel activity(GO:1901979) |
0.5 | 1.5 | GO:2000824 | negative regulation of androgen receptor activity(GO:2000824) |
0.5 | 2.4 | GO:0008611 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
0.5 | 1.4 | GO:0046168 | glycerol-3-phosphate catabolic process(GO:0046168) |
0.5 | 2.8 | GO:0098886 | modification of dendritic spine(GO:0098886) |
0.5 | 3.8 | GO:0086048 | membrane depolarization during bundle of His cell action potential(GO:0086048) |
0.5 | 1.4 | GO:0002184 | cytoplasmic translational termination(GO:0002184) |
0.5 | 2.3 | GO:1990569 | GDP-fucose transport(GO:0015783) UDP-N-acetylglucosamine transport(GO:0015788) purine nucleotide-sugar transport(GO:0036079) UDP-N-acetylglucosamine transmembrane transport(GO:1990569) |
0.4 | 1.8 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
0.4 | 5.2 | GO:2000580 | positive regulation of microtubule motor activity(GO:2000576) regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000580) positive regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000582) |
0.4 | 1.7 | GO:0000354 | cis assembly of pre-catalytic spliceosome(GO:0000354) |
0.4 | 1.6 | GO:0042144 | vacuole fusion, non-autophagic(GO:0042144) |
0.4 | 2.7 | GO:2000771 | regulation of unidimensional cell growth(GO:0051510) negative regulation of unidimensional cell growth(GO:0051511) establishment of cell polarity regulating cell shape(GO:0071964) regulation of establishment or maintenance of cell polarity regulating cell shape(GO:2000769) positive regulation of establishment or maintenance of cell polarity regulating cell shape(GO:2000771) regulation of establishment of cell polarity regulating cell shape(GO:2000782) positive regulation of establishment of cell polarity regulating cell shape(GO:2000784) positive regulation of barbed-end actin filament capping(GO:2000814) |
0.4 | 2.7 | GO:0019918 | peptidyl-arginine methylation, to symmetrical-dimethyl arginine(GO:0019918) |
0.4 | 2.7 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.4 | 1.1 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
0.4 | 3.4 | GO:0030242 | pexophagy(GO:0030242) |
0.4 | 2.3 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.4 | 1.9 | GO:0035105 | sterol regulatory element binding protein import into nucleus(GO:0035105) |
0.4 | 3.4 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.4 | 1.1 | GO:0060629 | meiotic DNA double-strand break formation(GO:0042138) regulation of homologous chromosome segregation(GO:0060629) |
0.4 | 3.4 | GO:1903551 | regulation of extracellular exosome assembly(GO:1903551) |
0.4 | 2.2 | GO:0045917 | positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
0.4 | 1.4 | GO:0098968 | neurotransmitter receptor transport postsynaptic membrane to endosome(GO:0098968) |
0.3 | 3.1 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
0.3 | 2.8 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
0.3 | 3.1 | GO:0089700 | protein kinase D signaling(GO:0089700) |
0.3 | 4.9 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
0.3 | 1.9 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.3 | 3.5 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
0.3 | 0.9 | GO:0001579 | medium-chain fatty acid transport(GO:0001579) |
0.3 | 1.2 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.3 | 2.7 | GO:0042791 | 5S class rRNA transcription from RNA polymerase III type 1 promoter(GO:0042791) tRNA transcription from RNA polymerase III promoter(GO:0042797) |
0.3 | 1.2 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
0.3 | 4.5 | GO:1901838 | positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
0.3 | 1.4 | GO:0043686 | co-translational protein modification(GO:0043686) |
0.3 | 2.5 | GO:0090521 | glomerular visceral epithelial cell migration(GO:0090521) |
0.3 | 0.8 | GO:0035981 | tongue muscle cell differentiation(GO:0035981) positive regulation of skeletal muscle fiber differentiation(GO:1902811) regulation of tongue muscle cell differentiation(GO:2001035) positive regulation of tongue muscle cell differentiation(GO:2001037) |
0.3 | 6.4 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.3 | 9.6 | GO:0042753 | positive regulation of circadian rhythm(GO:0042753) |
0.3 | 2.6 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
0.2 | 2.0 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.2 | 2.2 | GO:0042327 | positive regulation of phosphorylation(GO:0042327) |
0.2 | 1.5 | GO:0018343 | protein farnesylation(GO:0018343) |
0.2 | 1.7 | GO:1901098 | positive regulation of autophagosome maturation(GO:1901098) |
0.2 | 2.3 | GO:0019264 | glycine biosynthetic process from serine(GO:0019264) |
0.2 | 3.2 | GO:1990416 | cellular response to brain-derived neurotrophic factor stimulus(GO:1990416) |
0.2 | 6.1 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.2 | 2.9 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.2 | 3.1 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.2 | 2.4 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
0.2 | 1.5 | GO:0051697 | protein delipidation(GO:0051697) |
0.2 | 1.9 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
0.2 | 0.8 | GO:0016267 | O-glycan processing, core 1(GO:0016267) |
0.2 | 0.6 | GO:1902824 | positive regulation of late endosome to lysosome transport(GO:1902824) |
0.2 | 0.6 | GO:0006429 | leucyl-tRNA aminoacylation(GO:0006429) |
0.2 | 1.0 | GO:0046778 | modification by virus of host mRNA processing(GO:0046778) |
0.2 | 8.2 | GO:0061641 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
0.2 | 1.0 | GO:0002032 | desensitization of G-protein coupled receptor protein signaling pathway by arrestin(GO:0002032) |
0.2 | 13.4 | GO:0042073 | intraciliary transport(GO:0042073) |
0.2 | 1.9 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) |
0.2 | 1.7 | GO:0030043 | actin filament fragmentation(GO:0030043) |
0.2 | 1.9 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.2 | 1.8 | GO:0002943 | tRNA dihydrouridine synthesis(GO:0002943) |
0.2 | 1.3 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.2 | 8.4 | GO:0071174 | mitotic spindle checkpoint(GO:0071174) |
0.2 | 1.3 | GO:1904382 | protein deglycosylation involved in glycoprotein catabolic process(GO:0035977) glycoprotein ERAD pathway(GO:0097466) mannose trimming involved in glycoprotein ERAD pathway(GO:1904382) |
0.2 | 4.9 | GO:0039529 | RIG-I signaling pathway(GO:0039529) |
0.2 | 1.6 | GO:0010265 | SCF complex assembly(GO:0010265) |
0.2 | 0.9 | GO:0097676 | histone H3-K36 dimethylation(GO:0097676) |
0.2 | 0.6 | GO:0031133 | regulation of axon diameter(GO:0031133) |
0.2 | 2.0 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.2 | 0.6 | GO:1990502 | dense core granule maturation(GO:1990502) |
0.1 | 0.4 | GO:0006424 | glutamyl-tRNA aminoacylation(GO:0006424) |
0.1 | 1.4 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
0.1 | 1.0 | GO:0021699 | cerebellum maturation(GO:0021590) cerebellar cortex maturation(GO:0021699) |
0.1 | 4.5 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.1 | 1.9 | GO:0000098 | sulfur amino acid catabolic process(GO:0000098) |
0.1 | 0.5 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
0.1 | 3.1 | GO:0042074 | cell migration involved in gastrulation(GO:0042074) |
0.1 | 0.8 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.1 | 3.4 | GO:0031297 | replication fork processing(GO:0031297) |
0.1 | 0.9 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.1 | 1.4 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.1 | 0.5 | GO:1903770 | regulation of telomere maintenance via recombination(GO:0032207) negative regulation of telomere maintenance via recombination(GO:0032208) negative regulation of single strand break repair(GO:1903517) negative regulation of beta-galactosidase activity(GO:1903770) telomere single strand break repair(GO:1903823) negative regulation of telomere single strand break repair(GO:1903824) |
0.1 | 3.2 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
0.1 | 0.4 | GO:0045002 | double-strand break repair via single-strand annealing(GO:0045002) negative regulation of double-strand break repair via single-strand annealing(GO:1901291) |
0.1 | 3.5 | GO:0010172 | embryonic body morphogenesis(GO:0010172) |
0.1 | 0.8 | GO:0097473 | cellular response to high light intensity(GO:0071486) retinal rod cell apoptotic process(GO:0097473) |
0.1 | 1.9 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
0.1 | 0.6 | GO:0061687 | detoxification of inorganic compound(GO:0061687) stress response to metal ion(GO:0097501) |
0.1 | 0.8 | GO:1903786 | mycotoxin catabolic process(GO:0043387) aflatoxin catabolic process(GO:0046223) organic heteropentacyclic compound catabolic process(GO:1901377) regulation of glutathione biosynthetic process(GO:1903786) positive regulation of glutathione biosynthetic process(GO:1903788) |
0.1 | 0.7 | GO:0072553 | terminal button organization(GO:0072553) |
0.1 | 0.8 | GO:0019474 | L-lysine catabolic process to acetyl-CoA(GO:0019474) L-lysine catabolic process(GO:0019477) L-lysine metabolic process(GO:0046440) |
0.1 | 0.9 | GO:0045003 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
0.1 | 0.8 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.1 | 0.3 | GO:1990918 | double-strand break repair involved in meiotic recombination(GO:1990918) |
0.1 | 5.1 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
0.1 | 1.3 | GO:0048341 | paraxial mesoderm formation(GO:0048341) |
0.1 | 0.7 | GO:1990481 | mRNA pseudouridine synthesis(GO:1990481) |
0.1 | 0.8 | GO:0019856 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
0.1 | 4.3 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.1 | 1.4 | GO:0006264 | mitochondrial DNA replication(GO:0006264) |
0.1 | 2.5 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.1 | 2.0 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.1 | 3.7 | GO:0006907 | pinocytosis(GO:0006907) |
0.1 | 1.4 | GO:0034378 | chylomicron assembly(GO:0034378) |
0.1 | 1.4 | GO:0006707 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.1 | 1.8 | GO:0001682 | tRNA 5'-leader removal(GO:0001682) |
0.1 | 1.4 | GO:2000628 | regulation of miRNA metabolic process(GO:2000628) |
0.1 | 2.1 | GO:0070734 | histone H3-K27 methylation(GO:0070734) |
0.1 | 1.1 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
0.1 | 1.1 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.1 | 10.0 | GO:0030166 | proteoglycan biosynthetic process(GO:0030166) |
0.1 | 1.1 | GO:0038003 | opioid receptor signaling pathway(GO:0038003) |
0.1 | 2.5 | GO:0032201 | telomere maintenance via semi-conservative replication(GO:0032201) |
0.1 | 5.1 | GO:0071353 | cellular response to interleukin-4(GO:0071353) |
0.1 | 2.7 | GO:0043651 | linoleic acid metabolic process(GO:0043651) |
0.1 | 0.7 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.1 | 0.7 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.1 | 2.2 | GO:0060044 | negative regulation of cardiac muscle cell proliferation(GO:0060044) |
0.1 | 2.2 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
0.1 | 0.7 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.1 | 0.5 | GO:0034227 | tRNA thio-modification(GO:0034227) |
0.1 | 2.0 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.1 | 1.9 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.1 | 0.6 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.1 | 0.1 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
0.1 | 2.5 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
0.1 | 0.9 | GO:0030916 | otic vesicle formation(GO:0030916) |
0.1 | 0.9 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.1 | 0.4 | GO:1904100 | regulation of protein O-linked glycosylation(GO:1904098) positive regulation of protein O-linked glycosylation(GO:1904100) |
0.1 | 2.6 | GO:0007080 | mitotic metaphase plate congression(GO:0007080) |
0.1 | 1.1 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.1 | 1.2 | GO:0046602 | regulation of mitotic centrosome separation(GO:0046602) |
0.1 | 2.0 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.1 | 0.6 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.1 | 1.3 | GO:0002244 | hematopoietic progenitor cell differentiation(GO:0002244) |
0.1 | 0.4 | GO:0090158 | endoplasmic reticulum membrane organization(GO:0090158) |
0.1 | 0.4 | GO:0098707 | ferrous iron import into cell(GO:0097460) ferrous iron import across plasma membrane(GO:0098707) |
0.1 | 1.4 | GO:1904380 | endoplasmic reticulum mannose trimming(GO:1904380) |
0.1 | 0.6 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.1 | 0.2 | GO:0023016 | signal transduction by trans-phosphorylation(GO:0023016) |
0.1 | 1.0 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.1 | 0.4 | GO:0052422 | modulation by symbiont of host molecular function(GO:0052055) modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
0.1 | 0.2 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.1 | 0.5 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
0.1 | 0.2 | GO:0042407 | cristae formation(GO:0042407) |
0.1 | 1.4 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.1 | 0.1 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
0.1 | 0.7 | GO:0009249 | protein lipoylation(GO:0009249) |
0.1 | 0.2 | GO:0035519 | protein K29-linked ubiquitination(GO:0035519) |
0.1 | 0.2 | GO:0006844 | acyl carnitine transport(GO:0006844) acyl carnitine transmembrane transport(GO:1902616) |
0.1 | 0.3 | GO:1904885 | beta-catenin destruction complex assembly(GO:1904885) |
0.1 | 2.0 | GO:0071431 | tRNA export from nucleus(GO:0006409) tRNA-containing ribonucleoprotein complex export from nucleus(GO:0071431) |
0.1 | 0.8 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
0.1 | 0.4 | GO:0080009 | mRNA methylation(GO:0080009) |
0.1 | 1.9 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.1 | 3.2 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
0.0 | 4.2 | GO:0007062 | sister chromatid cohesion(GO:0007062) |
0.0 | 0.4 | GO:0070987 | error-free translesion synthesis(GO:0070987) |
0.0 | 1.4 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.0 | 1.0 | GO:0001649 | osteoblast differentiation(GO:0001649) |
0.0 | 1.0 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.0 | 1.0 | GO:0016246 | RNA interference(GO:0016246) |
0.0 | 0.6 | GO:0001553 | luteinization(GO:0001553) |
0.0 | 0.3 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.0 | 1.9 | GO:0018146 | keratan sulfate biosynthetic process(GO:0018146) |
0.0 | 3.8 | GO:0030512 | negative regulation of transforming growth factor beta receptor signaling pathway(GO:0030512) |
0.0 | 0.9 | GO:0006744 | ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
0.0 | 0.5 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
0.0 | 0.8 | GO:0016575 | histone deacetylation(GO:0016575) |
0.0 | 1.3 | GO:0008334 | histone mRNA metabolic process(GO:0008334) |
0.0 | 0.2 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.0 | 3.8 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.0 | 1.3 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.0 | 0.3 | GO:0070862 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
0.0 | 0.5 | GO:0043982 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
0.0 | 2.4 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.0 | 0.2 | GO:0046985 | negative regulation of megakaryocyte differentiation(GO:0045653) positive regulation of hemoglobin biosynthetic process(GO:0046985) |
0.0 | 0.1 | GO:0033385 | geranylgeranyl diphosphate metabolic process(GO:0033385) geranylgeranyl diphosphate biosynthetic process(GO:0033386) |
0.0 | 0.2 | GO:2001270 | regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.0 | 0.3 | GO:0007059 | chromosome segregation(GO:0007059) |
0.0 | 0.1 | GO:2001016 | positive regulation of skeletal muscle cell differentiation(GO:2001016) |
0.0 | 0.7 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.0 | 0.2 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
0.0 | 0.7 | GO:0031167 | rRNA methylation(GO:0031167) |
0.0 | 0.2 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.0 | 1.6 | GO:2001240 | negative regulation of signal transduction in absence of ligand(GO:1901099) negative regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001240) |
0.0 | 0.6 | GO:1903830 | magnesium ion transmembrane transport(GO:1903830) |
0.0 | 1.0 | GO:0048025 | negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
0.0 | 1.0 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.0 | 0.4 | GO:0035635 | entry of bacterium into host cell(GO:0035635) |
0.0 | 1.0 | GO:1902751 | positive regulation of cell cycle G2/M phase transition(GO:1902751) |
0.0 | 0.2 | GO:0000012 | single strand break repair(GO:0000012) |
0.0 | 0.3 | GO:0006105 | succinate metabolic process(GO:0006105) |
0.0 | 0.5 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
0.0 | 4.4 | GO:0030879 | mammary gland development(GO:0030879) |
0.0 | 0.6 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.0 | 0.1 | GO:0042357 | thiamine diphosphate metabolic process(GO:0042357) |
0.0 | 1.5 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
0.0 | 2.7 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.0 | 1.0 | GO:0032456 | endocytic recycling(GO:0032456) |
0.0 | 0.8 | GO:2000144 | positive regulation of DNA-templated transcription, initiation(GO:2000144) |
0.0 | 1.3 | GO:0006968 | cellular defense response(GO:0006968) |
0.0 | 0.3 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
0.0 | 0.1 | GO:0015780 | nucleotide-sugar transport(GO:0015780) pyrimidine nucleotide-sugar transport(GO:0015781) |
0.0 | 1.2 | GO:0043550 | regulation of lipid kinase activity(GO:0043550) |
0.0 | 0.6 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.0 | 1.0 | GO:0046676 | negative regulation of insulin secretion(GO:0046676) |
0.0 | 0.4 | GO:0006465 | signal peptide processing(GO:0006465) |
0.0 | 1.2 | GO:0043631 | mRNA polyadenylation(GO:0006378) RNA polyadenylation(GO:0043631) |
0.0 | 1.2 | GO:0003382 | epithelial cell morphogenesis(GO:0003382) |
0.0 | 0.2 | GO:0016180 | snRNA processing(GO:0016180) |
0.0 | 1.0 | GO:0055010 | ventricular cardiac muscle tissue morphogenesis(GO:0055010) |
0.0 | 1.6 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.0 | 0.9 | GO:0015949 | nucleobase-containing small molecule interconversion(GO:0015949) |
0.0 | 0.3 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.0 | 0.3 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.0 | 2.1 | GO:1901800 | positive regulation of proteasomal protein catabolic process(GO:1901800) |
0.0 | 1.8 | GO:0035308 | negative regulation of protein dephosphorylation(GO:0035308) |
0.0 | 0.2 | GO:0006621 | protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
0.0 | 0.5 | GO:2000772 | regulation of cellular senescence(GO:2000772) |
0.0 | 0.2 | GO:0006661 | phosphatidylinositol biosynthetic process(GO:0006661) |
0.0 | 0.2 | GO:0070203 | regulation of establishment of protein localization to telomere(GO:0070203) positive regulation of establishment of protein localization to telomere(GO:1904851) |
0.0 | 1.4 | GO:0019233 | sensory perception of pain(GO:0019233) |
0.0 | 0.2 | GO:0000338 | protein deneddylation(GO:0000338) |
0.0 | 1.3 | GO:0032755 | positive regulation of interleukin-6 production(GO:0032755) |
0.0 | 1.0 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.0 | 0.5 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
0.0 | 0.6 | GO:0001947 | heart looping(GO:0001947) |
0.0 | 0.1 | GO:0044211 | CTP salvage(GO:0044211) |
0.0 | 4.0 | GO:0007160 | cell-matrix adhesion(GO:0007160) |
0.0 | 0.5 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.0 | 1.5 | GO:0030326 | embryonic limb morphogenesis(GO:0030326) embryonic appendage morphogenesis(GO:0035113) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.8 | 17.5 | GO:0070762 | nuclear pore transmembrane ring(GO:0070762) |
3.3 | 26.1 | GO:0032133 | chromosome passenger complex(GO:0032133) |
2.2 | 8.7 | GO:0031436 | BRCA1-BARD1 complex(GO:0031436) |
1.5 | 5.9 | GO:1990423 | RZZ complex(GO:1990423) |
1.3 | 3.9 | GO:0034455 | t-UTP complex(GO:0034455) |
1.1 | 3.4 | GO:0070685 | macropinocytic cup(GO:0070685) |
1.1 | 3.3 | GO:1990298 | mitotic checkpoint complex(GO:0033597) bub1-bub3 complex(GO:1990298) |
1.0 | 9.5 | GO:0016012 | sarcoglycan complex(GO:0016012) |
0.8 | 4.1 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.7 | 2.1 | GO:0035101 | FACT complex(GO:0035101) |
0.7 | 9.1 | GO:0000796 | condensin complex(GO:0000796) |
0.7 | 2.0 | GO:1902636 | kinociliary basal body(GO:1902636) |
0.6 | 9.5 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.6 | 7.8 | GO:0000778 | condensed nuclear chromosome kinetochore(GO:0000778) |
0.5 | 3.8 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.5 | 1.6 | GO:0070557 | PCNA-p21 complex(GO:0070557) |
0.5 | 3.4 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
0.5 | 3.4 | GO:0033565 | ESCRT-0 complex(GO:0033565) |
0.5 | 1.9 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
0.5 | 4.6 | GO:0005638 | lamin filament(GO:0005638) |
0.5 | 1.4 | GO:0018444 | translation release factor complex(GO:0018444) |
0.4 | 5.2 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.4 | 2.4 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.4 | 1.5 | GO:0005965 | protein farnesyltransferase complex(GO:0005965) |
0.4 | 1.4 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
0.4 | 4.9 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.3 | 5.6 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.3 | 1.3 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.3 | 2.2 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.3 | 3.4 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.3 | 4.0 | GO:0030870 | Mre11 complex(GO:0030870) |
0.3 | 10.1 | GO:0071682 | endocytic vesicle lumen(GO:0071682) |
0.3 | 2.4 | GO:0031415 | NatA complex(GO:0031415) |
0.3 | 2.7 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.3 | 1.2 | GO:0031251 | PAN complex(GO:0031251) |
0.2 | 1.2 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.2 | 2.3 | GO:0070552 | BRISC complex(GO:0070552) |
0.2 | 6.9 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.2 | 0.9 | GO:0032798 | Swi5-Sfr1 complex(GO:0032798) |
0.2 | 4.4 | GO:0000800 | lateral element(GO:0000800) |
0.2 | 3.8 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.2 | 2.4 | GO:0097255 | R2TP complex(GO:0097255) |
0.2 | 3.6 | GO:0016600 | flotillin complex(GO:0016600) |
0.2 | 3.8 | GO:0031209 | SCAR complex(GO:0031209) |
0.2 | 1.0 | GO:0031417 | NatC complex(GO:0031417) |
0.2 | 1.4 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.2 | 0.6 | GO:0034657 | GID complex(GO:0034657) |
0.2 | 1.8 | GO:0005655 | nucleolar ribonuclease P complex(GO:0005655) |
0.2 | 0.5 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.2 | 1.1 | GO:0032311 | angiogenin-PRI complex(GO:0032311) |
0.2 | 1.6 | GO:0033263 | CORVET complex(GO:0033263) |
0.2 | 2.2 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.2 | 2.0 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.2 | 1.7 | GO:0001739 | sex chromatin(GO:0001739) |
0.1 | 1.3 | GO:0005683 | U7 snRNP(GO:0005683) |
0.1 | 15.1 | GO:0005871 | kinesin complex(GO:0005871) |
0.1 | 2.3 | GO:0035102 | PRC1 complex(GO:0035102) |
0.1 | 5.7 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.1 | 5.2 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.1 | 1.0 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.1 | 5.0 | GO:0070822 | Sin3-type complex(GO:0070822) |
0.1 | 0.9 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.1 | 1.3 | GO:0032584 | growth cone membrane(GO:0032584) |
0.1 | 0.4 | GO:0045293 | MIS complex(GO:0036396) mRNA editing complex(GO:0045293) |
0.1 | 9.4 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.1 | 1.2 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.1 | 1.3 | GO:0034709 | methylosome(GO:0034709) |
0.1 | 1.7 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.1 | 2.6 | GO:0098563 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.1 | 1.1 | GO:0000445 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.1 | 3.7 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.1 | 3.0 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.1 | 6.1 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.1 | 7.9 | GO:1904724 | tertiary granule lumen(GO:1904724) |
0.1 | 1.4 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.1 | 9.3 | GO:0043657 | host(GO:0018995) host cell(GO:0043657) |
0.1 | 0.3 | GO:0045257 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
0.1 | 1.9 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.1 | 2.4 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.1 | 1.7 | GO:0051233 | spindle midzone(GO:0051233) |
0.1 | 0.4 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.1 | 5.7 | GO:0016235 | aggresome(GO:0016235) |
0.1 | 1.0 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.1 | 2.7 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.1 | 0.9 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
0.1 | 0.4 | GO:0005784 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.1 | 2.2 | GO:0035861 | site of double-strand break(GO:0035861) |
0.1 | 1.7 | GO:0005682 | U5 snRNP(GO:0005682) |
0.1 | 1.8 | GO:0071565 | nBAF complex(GO:0071565) |
0.1 | 5.9 | GO:0000777 | condensed chromosome kinetochore(GO:0000777) |
0.1 | 1.4 | GO:0031105 | septin complex(GO:0031105) |
0.1 | 0.5 | GO:0005955 | calcineurin complex(GO:0005955) |
0.1 | 3.4 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.0 | 0.4 | GO:0005787 | signal peptidase complex(GO:0005787) |
0.0 | 1.0 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.0 | 1.2 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.0 | 3.1 | GO:0005762 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.0 | 0.8 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.0 | 4.5 | GO:0099501 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.0 | 0.7 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.0 | 2.7 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.0 | 1.4 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
0.0 | 2.0 | GO:0005657 | replication fork(GO:0005657) |
0.0 | 0.7 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.0 | 3.3 | GO:0072686 | mitotic spindle(GO:0072686) |
0.0 | 0.9 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.0 | 2.6 | GO:0015030 | Cajal body(GO:0015030) |
0.0 | 1.2 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.0 | 3.0 | GO:0043198 | dendritic shaft(GO:0043198) |
0.0 | 0.4 | GO:0000776 | kinetochore(GO:0000776) |
0.0 | 0.4 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.0 | 1.7 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.0 | 3.2 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.0 | 7.5 | GO:0031256 | leading edge membrane(GO:0031256) |
0.0 | 0.2 | GO:0005915 | zonula adherens(GO:0005915) |
0.0 | 0.2 | GO:0061617 | MICOS complex(GO:0061617) |
0.0 | 1.0 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.0 | 0.4 | GO:0070652 | HAUS complex(GO:0070652) |
0.0 | 1.4 | GO:0016592 | mediator complex(GO:0016592) |
0.0 | 1.6 | GO:0035579 | specific granule membrane(GO:0035579) |
0.0 | 1.8 | GO:0000794 | condensed nuclear chromosome(GO:0000794) |
0.0 | 2.6 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.0 | 1.8 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.0 | 1.3 | GO:0032420 | stereocilium(GO:0032420) |
0.0 | 0.6 | GO:0030315 | T-tubule(GO:0030315) |
0.0 | 0.1 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.0 | 0.9 | GO:0012505 | endomembrane system(GO:0012505) |
0.0 | 0.5 | GO:0005813 | centrosome(GO:0005813) |
0.0 | 6.0 | GO:0005819 | spindle(GO:0005819) |
0.0 | 0.5 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.0 | 3.3 | GO:0016363 | nuclear matrix(GO:0016363) |
0.0 | 0.5 | GO:0090545 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.0 | 0.3 | GO:0000812 | Swr1 complex(GO:0000812) |
0.0 | 0.6 | GO:0030056 | hemidesmosome(GO:0030056) |
0.0 | 2.9 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.0 | 0.5 | GO:0015630 | microtubule cytoskeleton(GO:0015630) |
0.0 | 0.1 | GO:1990130 | Iml1 complex(GO:1990130) |
0.0 | 1.7 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.0 | 1.7 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.0 | 0.3 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.0 | 0.3 | GO:0098803 | respiratory chain complex(GO:0098803) |
0.0 | 0.1 | GO:1990745 | EARP complex(GO:1990745) |
0.0 | 0.2 | GO:0032039 | integrator complex(GO:0032039) |
0.0 | 1.6 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.0 | 1.5 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.0 | 0.2 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.0 | 1.1 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.0 | 2.2 | GO:0072562 | blood microparticle(GO:0072562) |
0.0 | 5.7 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.0 | 0.5 | GO:0030658 | transport vesicle membrane(GO:0030658) |
0.0 | 0.1 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.7 | 8.4 | GO:0004382 | guanosine-diphosphatase activity(GO:0004382) |
1.5 | 4.6 | GO:0015068 | amidinotransferase activity(GO:0015067) glycine amidinotransferase activity(GO:0015068) |
1.3 | 3.8 | GO:0086057 | voltage-gated calcium channel activity involved in bundle of His cell action potential(GO:0086057) |
1.3 | 5.0 | GO:0004583 | dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity(GO:0004583) |
1.2 | 9.5 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
1.1 | 2.3 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
1.0 | 3.0 | GO:0016781 | selenide, water dikinase activity(GO:0004756) phosphotransferase activity, paired acceptors(GO:0016781) |
1.0 | 3.9 | GO:0004057 | arginyltransferase activity(GO:0004057) |
0.9 | 3.8 | GO:0003896 | DNA primase activity(GO:0003896) |
0.9 | 2.7 | GO:0045485 | omega-6 fatty acid desaturase activity(GO:0045485) |
0.9 | 2.7 | GO:0004019 | adenylosuccinate synthase activity(GO:0004019) |
0.8 | 4.7 | GO:0035402 | histone kinase activity (H3-T11 specific)(GO:0035402) |
0.7 | 2.9 | GO:0046404 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
0.7 | 10.1 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.6 | 5.1 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.6 | 20.0 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.6 | 2.3 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
0.5 | 3.2 | GO:0097001 | ceramide binding(GO:0097001) |
0.5 | 2.9 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) linoleoyl-CoA desaturase activity(GO:0016213) 5'-flap endonuclease activity(GO:0017108) |
0.5 | 2.4 | GO:0098626 | methylselenol reductase activity(GO:0098625) methylseleninic acid reductase activity(GO:0098626) |
0.5 | 1.4 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.5 | 2.3 | GO:0005462 | GDP-fucose transmembrane transporter activity(GO:0005457) UDP-N-acetylglucosamine transmembrane transporter activity(GO:0005462) purine nucleotide-sugar transmembrane transporter activity(GO:0036080) |
0.5 | 7.3 | GO:0000182 | rDNA binding(GO:0000182) |
0.4 | 4.9 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.4 | 1.8 | GO:0098808 | mRNA cap binding(GO:0098808) |
0.4 | 24.4 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.4 | 1.6 | GO:0001888 | glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0001888) |
0.4 | 6.1 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.4 | 3.2 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.4 | 1.6 | GO:0030337 | DNA polymerase processivity factor activity(GO:0030337) |
0.4 | 2.0 | GO:0002046 | opsin binding(GO:0002046) |
0.4 | 2.7 | GO:0035243 | protein-arginine omega-N symmetric methyltransferase activity(GO:0035243) |
0.4 | 1.5 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.4 | 1.5 | GO:0004660 | protein farnesyltransferase activity(GO:0004660) |
0.4 | 2.2 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.4 | 1.5 | GO:0035939 | microsatellite binding(GO:0035939) |
0.4 | 1.4 | GO:0004637 | phosphoribosylamine-glycine ligase activity(GO:0004637) phosphoribosylformylglycinamidine cyclo-ligase activity(GO:0004641) phosphoribosylglycinamide formyltransferase activity(GO:0004644) |
0.4 | 3.9 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.3 | 1.4 | GO:0047708 | biotinidase activity(GO:0047708) |
0.3 | 1.0 | GO:0031859 | platelet activating factor receptor binding(GO:0031859) |
0.3 | 0.9 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.3 | 4.0 | GO:0003910 | DNA ligase (ATP) activity(GO:0003910) |
0.3 | 4.5 | GO:0043142 | single-stranded DNA-dependent ATPase activity(GO:0043142) |
0.3 | 1.4 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.3 | 4.4 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.3 | 3.0 | GO:0070915 | lysophosphatidic acid binding(GO:0035727) lysophosphatidic acid receptor activity(GO:0070915) |
0.3 | 5.6 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.3 | 3.5 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
0.2 | 1.9 | GO:0004466 | long-chain-acyl-CoA dehydrogenase activity(GO:0004466) |
0.2 | 2.1 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.2 | 2.3 | GO:0004372 | glycine hydroxymethyltransferase activity(GO:0004372) threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
0.2 | 5.3 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.2 | 1.1 | GO:0047057 | oxidoreductase activity, acting on the CH-OH group of donors, disulfide as acceptor(GO:0016900) vitamin-K-epoxide reductase (warfarin-sensitive) activity(GO:0047057) |
0.2 | 6.0 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.2 | 2.9 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.2 | 3.0 | GO:0034452 | dynactin binding(GO:0034452) |
0.2 | 2.8 | GO:0008297 | single-stranded DNA exodeoxyribonuclease activity(GO:0008297) |
0.2 | 0.8 | GO:0009041 | uridylate kinase activity(GO:0009041) |
0.2 | 0.8 | GO:0016263 | glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity(GO:0016263) |
0.2 | 0.6 | GO:0004823 | leucine-tRNA ligase activity(GO:0004823) |
0.2 | 1.2 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.2 | 1.6 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
0.2 | 7.8 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.2 | 3.4 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.2 | 2.0 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.2 | 2.0 | GO:0035005 | lipid kinase activity(GO:0001727) 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.2 | 6.1 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.2 | 1.8 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.2 | 3.8 | GO:0051400 | BH domain binding(GO:0051400) |
0.2 | 1.4 | GO:0008079 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.2 | 0.3 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.2 | 2.0 | GO:0000990 | transcription factor activity, core RNA polymerase binding(GO:0000990) |
0.2 | 1.2 | GO:0061649 | ubiquitinated histone binding(GO:0061649) |
0.2 | 3.1 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
0.2 | 1.8 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.2 | 2.3 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
0.1 | 0.4 | GO:0004818 | glutamate-tRNA ligase activity(GO:0004818) |
0.1 | 0.4 | GO:0003880 | protein C-terminal carboxyl O-methyltransferase activity(GO:0003880) |
0.1 | 1.3 | GO:0030621 | U4 snRNA binding(GO:0030621) |
0.1 | 2.0 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.1 | 0.5 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.1 | 0.9 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.1 | 0.8 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.1 | 0.6 | GO:0010465 | nerve growth factor receptor activity(GO:0010465) |
0.1 | 3.0 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
0.1 | 0.4 | GO:0034039 | 8-oxo-7,8-dihydroguanine DNA N-glycosylase activity(GO:0034039) |
0.1 | 0.8 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.1 | 10.9 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.1 | 3.6 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.1 | 1.1 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.1 | 1.4 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.1 | 0.7 | GO:0000179 | rRNA (adenine-N6,N6-)-dimethyltransferase activity(GO:0000179) |
0.1 | 0.4 | GO:0004998 | transferrin receptor activity(GO:0004998) |
0.1 | 1.0 | GO:1990446 | U1 snRNP binding(GO:1990446) |
0.1 | 1.8 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.1 | 9.6 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.1 | 3.1 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
0.1 | 2.3 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.1 | 0.4 | GO:0052642 | lysophosphatidic acid phosphatase activity(GO:0052642) |
0.1 | 1.8 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.1 | 0.8 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.1 | 0.7 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.1 | 0.3 | GO:0001133 | RNA polymerase II transcription factor activity, sequence-specific transcription regulatory region DNA binding(GO:0001133) |
0.1 | 3.1 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.1 | 1.1 | GO:0008428 | ribonuclease inhibitor activity(GO:0008428) |
0.1 | 1.3 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.1 | 1.2 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.1 | 2.4 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.1 | 2.0 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.1 | 1.0 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.1 | 6.4 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.1 | 0.6 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.1 | 4.9 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.1 | 1.5 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.1 | 1.9 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.1 | 0.5 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.1 | 7.8 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.1 | 0.6 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.1 | 0.4 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.1 | 1.1 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.1 | 1.9 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
0.1 | 4.7 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.1 | 1.3 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.1 | 0.2 | GO:0015227 | acyl carnitine transmembrane transporter activity(GO:0015227) |
0.1 | 1.4 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.1 | 4.9 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.0 | 1.8 | GO:0070034 | telomerase RNA binding(GO:0070034) |
0.0 | 2.4 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.0 | 1.9 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.0 | 0.5 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.0 | 1.7 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.0 | 0.7 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.0 | 4.0 | GO:0019003 | GDP binding(GO:0019003) |
0.0 | 1.5 | GO:0071949 | FAD binding(GO:0071949) |
0.0 | 1.9 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.0 | 0.4 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.0 | 0.9 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.0 | 1.4 | GO:0042165 | neurotransmitter binding(GO:0042165) |
0.0 | 0.2 | GO:0005046 | KDEL sequence binding(GO:0005046) |
0.0 | 1.6 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.0 | 4.1 | GO:0002039 | p53 binding(GO:0002039) |
0.0 | 6.5 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.0 | 0.6 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.0 | 0.6 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.0 | 3.2 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.0 | 0.5 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.0 | 0.1 | GO:0050333 | thiamin-triphosphatase activity(GO:0050333) |
0.0 | 2.1 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.0 | 1.4 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.0 | 0.5 | GO:0043996 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.0 | 0.7 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.0 | 0.8 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.0 | 0.2 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.0 | 2.6 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.0 | 0.9 | GO:0061650 | ubiquitin conjugating enzyme activity(GO:0061631) ubiquitin-like protein conjugating enzyme activity(GO:0061650) |
0.0 | 0.4 | GO:0043559 | insulin binding(GO:0043559) |
0.0 | 0.6 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.0 | 0.2 | GO:0001042 | RNA polymerase I core binding(GO:0001042) |
0.0 | 2.0 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.0 | 0.2 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
0.0 | 0.2 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.0 | 0.3 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.0 | 0.4 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
0.0 | 1.6 | GO:0043621 | protein self-association(GO:0043621) |
0.0 | 0.7 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.0 | 0.5 | GO:0044822 | mRNA binding(GO:0003729) poly(A) RNA binding(GO:0044822) |
0.0 | 1.0 | GO:0004521 | endoribonuclease activity(GO:0004521) |
0.0 | 0.7 | GO:0030371 | translation repressor activity(GO:0030371) |
0.0 | 0.9 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.0 | 0.1 | GO:0004161 | dimethylallyltranstransferase activity(GO:0004161) geranyltranstransferase activity(GO:0004337) |
0.0 | 1.8 | GO:0008565 | protein transporter activity(GO:0008565) |
0.0 | 0.6 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.0 | 1.7 | GO:0032947 | protein complex scaffold(GO:0032947) |
0.0 | 0.6 | GO:0015002 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.0 | 0.2 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.0 | 0.2 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
0.0 | 0.9 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.0 | 0.1 | GO:0015165 | nucleotide-sugar transmembrane transporter activity(GO:0005338) pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.0 | 1.8 | GO:1902936 | phosphatidylinositol bisphosphate binding(GO:1902936) |
0.0 | 0.6 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.0 | 1.6 | GO:0030276 | clathrin binding(GO:0030276) |
0.0 | 8.1 | GO:0030695 | GTPase regulator activity(GO:0030695) |
0.0 | 1.5 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.0 | 0.2 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.0 | 0.4 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.0 | 0.5 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.0 | 2.1 | GO:0015171 | amino acid transmembrane transporter activity(GO:0015171) |
0.0 | 1.0 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.0 | 0.6 | GO:0030506 | ankyrin binding(GO:0030506) |
0.0 | 0.1 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.0 | 0.3 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.0 | 1.3 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.0 | 1.6 | GO:0005518 | collagen binding(GO:0005518) |
0.0 | 0.3 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
0.0 | 7.1 | GO:0046982 | protein heterodimerization activity(GO:0046982) |
0.0 | 2.4 | GO:0008201 | heparin binding(GO:0008201) |
0.0 | 0.2 | GO:0005537 | mannose binding(GO:0005537) |
0.0 | 1.4 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 0.1 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.0 | 0.8 | GO:0004004 | ATP-dependent RNA helicase activity(GO:0004004) RNA-dependent ATPase activity(GO:0008186) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 44.8 | PID AURORA B PATHWAY | Aurora B signaling |
0.3 | 27.0 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.3 | 13.1 | PID ATR PATHWAY | ATR signaling pathway |
0.2 | 5.4 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.2 | 4.7 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.2 | 7.1 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.1 | 5.1 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.1 | 10.6 | PID P53 REGULATION PATHWAY | p53 pathway |
0.1 | 2.4 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.1 | 5.0 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.1 | 5.0 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.1 | 3.7 | PID PLK1 PATHWAY | PLK1 signaling events |
0.1 | 3.0 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.1 | 3.4 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.1 | 2.1 | ST GAQ PATHWAY | G alpha q Pathway |
0.0 | 1.4 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.0 | 4.5 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.0 | 4.7 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.0 | 2.0 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.0 | 1.2 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.0 | 6.2 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.0 | 2.4 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.0 | 1.5 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.0 | 0.6 | PID RHOA PATHWAY | RhoA signaling pathway |
0.0 | 0.6 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.0 | 1.3 | PID INSULIN PATHWAY | Insulin Pathway |
0.0 | 0.7 | PID ARF 3PATHWAY | Arf1 pathway |
0.0 | 4.3 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.0 | 0.7 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.0 | 0.6 | PID BARD1 PATHWAY | BARD1 signaling events |
0.0 | 1.3 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.0 | 1.9 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.0 | 2.4 | PID P73PATHWAY | p73 transcription factor network |
0.0 | 1.7 | PID E2F PATHWAY | E2F transcription factor network |
0.0 | 0.5 | PID ATM PATHWAY | ATM pathway |
0.0 | 1.2 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.0 | 1.3 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.0 | 1.3 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.0 | 0.9 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.0 | 0.3 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 8.9 | REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
0.6 | 8.3 | REACTOME PROCESSIVE SYNTHESIS ON THE LAGGING STRAND | Genes involved in Processive synthesis on the lagging strand |
0.5 | 19.2 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.4 | 54.2 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.3 | 12.9 | REACTOME KINESINS | Genes involved in Kinesins |
0.3 | 1.6 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.2 | 8.8 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
0.2 | 7.8 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.2 | 4.1 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.2 | 5.2 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.2 | 2.7 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.2 | 1.0 | REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
0.1 | 5.1 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.1 | 5.3 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.1 | 3.4 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.1 | 4.1 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.1 | 2.6 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
0.1 | 3.3 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
0.1 | 2.7 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.1 | 1.3 | REACTOME PROCESSING OF CAPPED INTRONLESS PRE MRNA | Genes involved in Processing of Capped Intronless Pre-mRNA |
0.1 | 6.0 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
0.1 | 6.1 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.1 | 3.1 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.1 | 1.9 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.1 | 8.6 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.1 | 8.4 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.1 | 4.9 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.1 | 2.9 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.1 | 3.4 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.1 | 1.1 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.1 | 6.9 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.1 | 2.1 | REACTOME MRNA SPLICING MINOR PATHWAY | Genes involved in mRNA Splicing - Minor Pathway |
0.1 | 3.4 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.1 | 1.3 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.1 | 1.9 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.1 | 0.8 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.1 | 0.4 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.1 | 4.8 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.1 | 3.3 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.0 | 1.6 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
0.0 | 1.1 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.0 | 0.1 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
0.0 | 2.2 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
0.0 | 1.4 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
0.0 | 1.6 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.0 | 1.3 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.0 | 1.9 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.0 | 1.0 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.0 | 1.4 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.0 | 0.5 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.0 | 0.8 | REACTOME HOST INTERACTIONS OF HIV FACTORS | Genes involved in Host Interactions of HIV factors |
0.0 | 0.2 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.0 | 0.3 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.0 | 0.4 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.0 | 1.4 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.0 | 1.0 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.0 | 0.2 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.0 | 2.0 | REACTOME APOPTOTIC EXECUTION PHASE | Genes involved in Apoptotic execution phase |
0.0 | 0.6 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.0 | 1.5 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.0 | 0.6 | REACTOME TRNA AMINOACYLATION | Genes involved in tRNA Aminoacylation |
0.0 | 2.2 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.0 | 4.2 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.0 | 0.6 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.0 | 0.3 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.0 | 0.6 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.0 | 2.7 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.0 | 0.8 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |